Affinage

CEP70

Centrosomal protein of 70 kDa · UniProt Q8NHQ1

Length
597 aa
Mass
69.8 kDa
Annotated
2026-06-09
100 papers in source corpus 9 papers cited in narrative 9 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 8/8 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

CEP70 is a centrosomal protein that organizes the microtubule cytoskeleton by binding γ-tubulin and directly promoting microtubule elongation, with essential roles in mitotic spindle assembly, ciliogenesis, and cell migration (PMID:21795687, PMID:22427462). It localizes to the centrosome throughout the cell cycle and interacts with γ-tubulin via coiled-coil-containing fragments, an association required for its own centrosomal targeting; loss of CEP70 disrupts interphase microtubule organization and produces mis-oriented, poorly bipolar mitotic spindles (PMID:21795687). In vitro, purified CEP70 increases microtubule length without changing microtubule number, establishing that it acts as a direct elongation factor rather than a nucleator (PMID:22427462). CEP70 additionally interacts with the deacetylase HDAC6 in the cytoplasm and promotes tubulin acetylation, stabilizing microtubules against cold- and nocodazole-induced depolymerization (PMID:26112604). Its centrosomal function is gated by the deubiquitinase CYLD, which removes polyubiquitin from CEP70 to permit γ-tubulin binding and centrosomal localization, thereby enabling axoneme elongation during ciliogenesis (PMID:25342559); consistent with this, CEP70 is required for cilium elongation (but not basal body formation) across tissues (PMID:19254375). Through reorganization of microtubules and activation of the Rho-family GTPases Cdc42 and Rac1, CEP70 drives centrosome reorientation, endothelial cell migration, and angiogenesis (PMID:22437770). CEP70 is also essential for spermiogenesis, where its loss causes germ-cell apoptosis and defective flagella and acrosome formation, and a heterozygous CEP70 mutation has been identified in a patient with azoospermia (PMID:33980814). CEP70 dosage is tightly constrained: its overexpression mislocalizes γ-tubulin and pericentrin, disorganizes microtubules, and induces multipolar spindles (PMID:26893288).

Mechanistic history

Synthesis pass · year-by-year structured walk · 9 steps
  1. 2009 Medium

    Establishing whether CEP70 acts in cilium assembly addressed whether the protein is a general cytoskeletal factor or a dedicated ciliary component; the ortholog study placed it specifically in axoneme elongation downstream of basal body formation.

    Evidence Morpholino knockdown of Cep70 in zebrafish with electron microscopy and ciliary/centrosomal immunofluorescence

    PMID:19254375

    Open questions at the time
    • Does not define the molecular partners mediating axoneme elongation
    • Ortholog/morpholino approach without rescue specificity controls noted
    • Yeast two-hybrid failed to detect HDAC6 or IFT interactions, leaving the mechanism of elongation undefined
  2. 2011 High

    Identifying γ-tubulin as a direct CEP70 partner and mapping the coiled-coil interaction defined the molecular basis for centrosomal targeting and explained CEP70's role in microtubule and spindle organization.

    Evidence Reciprocal Co-IP with domain-mapping pulldowns and siRNA knockdown with spindle phenotype analysis in cultured cells

    PMID:21795687

    Open questions at the time
    • Does not show whether γ-tubulin binding alone is sufficient for microtubule elongation
    • Mechanism linking spindle mis-orientation to the γ-tubulin interaction not resolved
  3. 2011 Medium

    The Chlamydomonas ortholog study tested whether CEP70 functions in centriole biogenesis itself, showing scaffold activity for recruiting core centriolar proteins to procentrioles.

    Evidence RNAi knockdown and overexpression of CRC70 in Chlamydomonas and NIH3T3 cells with immunolocalization

    PMID:21878503

    Open questions at the time
    • Centriole-scaffold role conflicts with the axoneme-elongation-only role seen in zebrafish, leaving species/context generality unresolved
    • Whether mammalian CEP70 recruits SAS-6/Bld10p orthologs not tested
  4. 2012 High

    Direct in vitro reconstitution settled whether CEP70 nucleates or elongates microtubules, demonstrating it stimulates elongation without altering microtubule number.

    Evidence In vitro microtubule assembly assay with purified CEP70 and tubulin

    PMID:22427462

    Open questions at the time
    • Does not identify the structural mechanism of elongation promotion
    • Whether γ-tubulin or HDAC6 modulate this in vitro activity not tested
  5. 2012 High

    Linking CEP70 to Cdc42/Rac1 activation and directed migration connected its microtubule function to a physiological output, angiogenesis.

    Evidence siRNA knockdown in endothelial cells with migration, tube formation, in vivo angiogenesis, and GTPase pull-down assays

    PMID:22437770

    Open questions at the time
    • Mechanism connecting centrosomal microtubule organization to Cdc42/Rac1 activation not defined
    • Whether GTPase activation is direct or downstream of cytoskeletal reorganization unresolved
  6. 2014 High

    Identifying CYLD-mediated deubiquitination as a prerequisite for γ-tubulin binding and centrosomal localization provided the regulatory switch controlling CEP70 ciliary function.

    Evidence CYLD knockout mice with deubiquitination assays, Co-IP, localization analysis, and rescue experiments

    PMID:25342559

    Open questions at the time
    • Ubiquitin ligase that adds the chains removed by CYLD not identified
    • Ubiquitination sites on CEP70 not mapped
  7. 2015 Medium

    The HDAC6 interaction explained how CEP70 confers microtubule stability, linking it to tubulin acetylation control.

    Evidence Co-IP and colocalization with HDAC6, plus siRNA knockdown with cold/nocodazole stability assays and acetylation immunoblotting

    PMID:26112604

    Open questions at the time
    • Whether CEP70 inhibits or activates HDAC6 enzymatic activity not directly resolved
    • Single-lab Co-IP without reciprocal validation across systems
    • Zebrafish two-hybrid did not detect this interaction, leaving conservation unclear
  8. 2016 Medium

    Overexpression experiments revealed that CEP70 dosage is constrained, with excess protein driving centrosome abnormality and genomic instability relevant to cancer.

    Evidence Ectopic overexpression and siRNA in pancreatic cancer cells with immunofluorescence, colony formation, and xenograft assays

    PMID:26893288

    Open questions at the time
    • Does not establish endogenous CEP70 dysregulation in patient tumors
    • Mechanism by which excess CEP70 mislocalizes pericentrin/γ-tubulin not defined
  9. 2021 High

    Mouse knockout and human mutation screening established CEP70 as essential for spermiogenesis and linked it to clinical azoospermia.

    Evidence CEP70 knockout mice with TEM/SEM ultrastructure, TMT quantitative proteomics, and human mutation screening

    PMID:33980814

    Open questions at the time
    • Causality of the heterozygous human variant not established by functional or family genetics
    • Mechanism connecting CEP70 loss to germ-cell apoptosis versus flagellar defects not separated

Open questions

Synthesis pass · forward-looking unresolved questions
  • How CEP70's distinct activities — γ-tubulin binding, direct microtubule elongation, HDAC6-dependent acetylation, and CYLD-gated ciliary localization — are integrated and differentially deployed across mitosis, ciliogenesis, migration, and spermiogenesis remains unresolved.
  • No structure of CEP70 or its γ-tubulin/HDAC6 complexes
  • Ubiquitin ligase opposing CYLD unidentified
  • Reconciliation of centriole-scaffold versus axoneme-elongation roles across species pending

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0008092 cytoskeletal protein binding 3 GO:0060090 molecular adaptor activity 2
Localization
GO:0005815 microtubule organizing center 3 GO:0005929 cilium 2 GO:0005829 cytosol 1
Pathway
R-HSA-1266738 Developmental Biology 2 R-HSA-1852241 Organelle biogenesis and maintenance 2 R-HSA-1640170 Cell Cycle 1
Partners

Evidence

Reading pass · 9 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2011 CEP70 localizes to the centrosome throughout the cell cycle and physically interacts with γ-tubulin through peptide fragments containing coiled-coil domains; this interaction is required for centrosomal localization of CEP70. Depletion of CEP70 disrupts organization of both preexisting and nascent microtubules in interphase cells and impairs bipolar spindle organization and orientation during mitosis. Co-immunoprecipitation, domain-mapping pulldown assays, siRNA knockdown with immunofluorescence microscopy, and mitotic spindle phenotype analysis The Journal of biological chemistry High 21795687
2012 CEP70 is necessary for angiogenic response in vivo and for tube formation and capillary sprouting in vitro. Depletion of CEP70 impairs endothelial cell migration, membrane ruffling, and centrosome reorientation (cell polarization), and blocks microtubule rearrangement in response to migratory stimuli. CEP70 promotes activation of Cdc42 and Rac1 to drive angiogenesis. siRNA knockdown in vascular endothelial cells, wound-healing and transwell migration assays, tube formation assay, in vivo angiogenesis assay, GTPase activity assays (Cdc42/Rac1 pull-down) Cell cycle (Georgetown, Tex.) High 22437770
2012 Purified CEP70 protein promotes microtubule elongation in vitro, increasing microtubule length without affecting microtubule number, indicating that CEP70 directly stimulates microtubule elongation rather than nucleation. In vitro microtubule assembly assay using purified CEP70 protein and tubulin Acta biochimica et biophysica Sinica High 22427462
2014 CYLD deubiquitinase removes polyubiquitin chains from CEP70; this deubiquitination is required for CEP70 to interact with γ-tubulin and localize at the centrosome, thereby enabling ciliogenesis. In CYLD knockout mice, cilia fail to form properly, basal body anchorage fails, and axoneme organization is disrupted, phenotypes partially attributable to loss of CEP70 deubiquitination. CYLD knockout mice, deubiquitination assays, Co-immunoprecipitation (CEP70–γ-tubulin interaction), immunofluorescence for centrosomal localization, rescue experiments Cell research High 25342559
2015 CEP70 interacts with HDAC6 in the cytoplasm and promotes tubulin acetylation, thereby enhancing microtubule stability against cold or nocodazole-induced depolymerization. CEP70-dependent microtubule stabilization is mechanistically linked to regulation of HDAC6 activity. Co-immunoprecipitation and colocalization of CEP70 with HDAC6, siRNA knockdown of CEP70 with microtubule cold/nocodazole stability assays, tubulin acetylation immunoblotting FEBS letters Medium 26112604
2016 Overexpression of CEP70 in pancreatic cancer cells causes mislocalization of centrosomal proteins γ-tubulin and pericentrin, formation of intracellular aggregates, microtubule disorganization, and multipolar spindle formation during mitosis, linking CEP70 excess to centrosome abnormality and genomic instability. Ectopic overexpression in pancreatic cancer cell lines, immunofluorescence for centrosomal proteins, soft-agar colony formation, xenograft tumor growth, siRNA depletion with proliferation and apoptosis assays Scientific reports Medium 26893288
2009 Zebrafish Cep70 (ortholog of human CEP70) is required for ciliogenesis in multiple tissues; morpholino-mediated depletion results in shortened but not absent cilia in kidney, ear, and other organs, with defects in left–right asymmetry and kidney/ear development, phenocopying intraflagellar transport (IFT) mutants. Centrosomes and basal bodies remain present in morphants, indicating CEP70 functions in axoneme elongation rather than basal body formation. Morpholino knockdown in zebrafish embryos, electron microscopy, immunofluorescence for cilia and centrosomes, yeast two-hybrid (negative: no interaction with HDAC6 or IFTs detected) BMC cell biology Medium 19254375
2011 The Chlamydomonas CEP70 ortholog CRC70 preferentially localizes to immature centrioles (procentrioles) and functions as a scaffold for centriole assembly; RNAi knockdown of CRC70 prevents recruitment of SAS-6 and Bld10p to the centriole and produces flagella-less cells. Overexpression of CRC70 causes cytoplasmic aggregation of centriole components. Overexpression in mouse NIH3T3 cells induces centriole-like structures. RNAi knockdown in Chlamydomonas, immunolocalization, overexpression in Chlamydomonas and mammalian NIH3T3 cells Journal of cell science Medium 21878503
2021 CEP70 knockout in mice causes abnormal spermiogenesis: loss of CEP70 leads to male germ-cell apoptosis and defective formation of sperm flagella and acrosomes. Proteomic analysis (TMT) showed decreased abundance of proteins associated with flagella, sperm head, acrosome, and microtubule cytoskeleton. A heterozygous CEP70 mutation was identified in a patient with clinical azoospermia. CEP70 knockout mice, transmission electron microscopy, scanning electron microscopy, TMT-labeled quantitative proteomics, human mutation screening Cell death & disease High 33980814

Source papers

Stage 0 corpus · 100 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2010 Snake bite. Lancet (London, England) 599 20109866
2016 Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 350 26884582
2020 Anti-B-Cell Maturation Antigen BiTE Molecule AMG 420 Induces Responses in Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 250 31895611
2016 Blinatumomab, a Bispecific T-cell Engager (BiTE(®)) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its Implications. Clinical pharmacokinetics 175 27209293
2011 Immunomodulatory therapy of cancer with T cell-engaging BiTE antibody blinatumomab. Experimental cell research 161 21419116
2016 T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts. Oncotarget 154 27708227
2009 Mode of cytotoxic action of T cell-engaging BiTE antibody MT110. Immunobiology 150 19157637
2016 Blinatumomab: a CD19/CD3 bispecific T cell engager (BiTE) with unique anti-tumor efficacy. Leukemia & lymphoma 142 27050240
2010 T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells. Proceedings of the National Academy of Sciences of the United States of America 137 20616015
2016 Harnessing T cells to fight cancer with BiTE® antibody constructs--past developments and future directions. Immunological reviews 134 26864113
2015 Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymphoid leukemia. Journal of hematology & oncology 127 26337639
2020 Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors. Molecular therapy : the journal of the American Society of Gene Therapy 125 32145203
2009 BiTE: Teaching antibodies to engage T-cells for cancer therapy. Current opinion in molecular therapeutics 125 19169956
1989 Snake-bite-induced acute renal failure in India. Kidney international 113 2651763
2014 CYLD mediates ciliogenesis in multiple organs by deubiquitinating Cep70 and inactivating HDAC6. Cell research 106 25342559
2017 Bispecific T cell engager (BiTE®) antibody constructs can mediate bystander tumor cell killing. PloS one 100 28837681
2002 Taking a bite: proteasomal protein processing. Nature cell biology 94 11988749
2012 Equine insect bite hypersensitivity: what do we know? Veterinary immunology and immunopathology 92 22575371
2018 Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 91 29437789
2014 Blinatumomab, a Bi-Specific Anti-CD19/CD3 BiTE(®) Antibody for the Treatment of Acute Lymphoblastic Leukemia: Perspectives and Current Pediatric Applications. Frontiers in oncology 86 24744989
2009 Immunotherapy of lymphoma and leukemia with T-cell engaging BiTE antibody blinatumomab. Leukemia & lymphoma 85 19455460
2010 The first bite--profiling the predatosome in the bacterial pathogen Bdellovibrio. PloS one 82 20062540
2021 Bite of the wolf: innate immune responses propagate autoimmunity in lupus. The Journal of clinical investigation 81 33529160
2015 CEA/CD3-bispecific T cell-engaging (BiTE) antibody-mediated T lymphocyte cytotoxicity maximized by inhibition of both PD1 and PD-L1. Cancer immunology, immunotherapy : CII 81 25742933
2018 CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells. Journal for immunotherapy of cancer 77 30396365
2015 T-cell ligands modulate the cytolytic activity of the CD33/CD3 BiTE antibody construct, AMG 330. Blood cancer journal 69 26295610
2009 Cep70 and Cep131 contribute to ciliogenesis in zebrafish embryos. BMC cell biology 66 19254375
2022 Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient? Journal of hematology & oncology 58 35672793
2018 Treating insect-bite hypersensitivity in horses with active vaccination against IL-5. The Journal of allergy and clinical immunology 56 29627082
2023 BiTE-Secreting CAR-γδT as a Dual Targeting Strategy for the Treatment of Solid Tumors. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 55 37078788
2015 Utilizing the BiTE (bispecific T-cell engager) platform for immunotherapy of cancer. Expert opinion on biological therapy 55 25971805
2021 Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy. Journal for immunotherapy of cancer 51 33820820
1997 African tick-bite fever. An imported spotless rickettsiosis. Archives of internal medicine 50 8996049
2019 Taking a "BiTE out of ALL": blinatumomab approval for MRD-positive ALL. Blood 48 30796026
2020 Characterization of a Novel FLT3 BiTE Molecule for the Treatment of Acute Myeloid Leukemia. Molecular cancer therapeutics 45 32518207
2006 Rat-bite fever septic arthritis: illustrative case and literature review. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 44 17096137
1997 Characterization of saccharolytic Bacteroides and Prevotella isolates from infected dog and cat bite wounds in humans. Journal of clinical microbiology 41 9003606
2014 Cat bite infections of the hand: assessment of morbidity and predictors of severe infection. The Journal of hand surgery 40 24480688
2014 Unleashing the clinical power of T cells: CD19/CD3 bi-specific T cell engager (BiTE®) antibody construct blinatumomab as a potential therapy. International immunology 40 25239133
2017 Spontaneous and Bite-Evoked Muscle Pain Are Mediated by a Common Nociceptive Pathway With Differential Contribution by TRPV1. The journal of pain 38 28669862
2017 Clinicopathological spectrum of snake bite-induced acute kidney injury from India. World journal of nephrology 37 28540205
2016 Approved and novel strategies in diagnostics of rat bite fever and other Streptobacillus infections in humans and animals. Virulence 37 27088660
2013 Cloning and expression of candidate allergens from Culicoides obsoletus for diagnosis of insect bite hypersensitivity in horses. Veterinary immunology and immunopathology 37 23561552
2001 Immunoglobulin-E-bearing cells in skin biopsies of horses with insect bite hypersensitivity. Equine veterinary journal 37 11770993
2004 Coagulation in sepsis: all bugs bite equally. Critical care (London, England) 36 15025767
2015 Clinical overview of anti-CD19 BiTE(®) and ex vivo data from anti-CD33 BiTE(®) as examples for retargeting T cells in hematologic malignancies. Molecular immunology 35 25883042
2004 CAR chasing: canine adenovirus vectors-all bite and no bark? The journal of gene medicine 35 14978757
2021 Snake bite associated with acute kidney injury. Pediatric nephrology (Berlin, Germany) 33 33559706
2011 CEP70 protein interacts with γ-tubulin to localize at the centrosome and is critical for mitotic spindle assembly. The Journal of biological chemistry 33 21795687
2022 Update on mosquito bite reaction: Itch and hypersensitivity, pathophysiology, prevention, and treatment. Frontiers in immunology 31 36211437
2015 Taking a bite: Amoebic trogocytosis in Entamoeba histolytica and beyond. Current opinion in microbiology 31 26277085
2015 Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro. Journal of experimental & clinical cancer research : CR 31 26474755
2022 Cancer cell-intrinsic resistance to BiTE therapy is mediated by loss of CD58 costimulation and modulation of the extrinsic apoptotic pathway. Journal for immunotherapy of cancer 30 35296559
2022 Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells. Scientific reports 30 35418130
2018 To roll the eyes and snap a bite - function, development and evolution of craniofacial muscles. Seminars in cell & developmental biology 30 29331210
2012 Cep70 contributes to angiogenesis by modulating microtubule rearrangement and stimulating cell polarization and migration. Cell cycle (Georgetown, Tex.) 30 22437770
2024 New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses. Cell communication and signaling : CCS 29 38243252
2022 Predictability of overbite control with the Invisalign appliance comparing SmartTrack with precision bite ramps to EX30. American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics 28 35750579
2006 Hypersersensitivity and Kounis syndrome due to a viper bite. European journal of internal medicine 28 16618460
2021 Preclinical Assessment of AMG 596, a Bispecific T-cell Engager (BiTE) Immunotherapy Targeting the Tumor-specific Antigen EGFRvIII. Molecular cancer therapeutics 27 33632870
2021 Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas. Journal for immunotherapy of cancer 27 33963009
2007 A weak Lck tail bite is necessary for Lck function in T cell antigen receptor signaling. The Journal of biological chemistry 27 17897955
2021 Fn14-targeted BiTE and CAR-T cells demonstrate potent preclinical activity against glioblastoma. Oncoimmunology 26 34595061
2005 Insect bite-like reaction associated with mantle cell lymphoma: clinicopathological, immunopathological, and molecular studies. The American Journal of dermatopathology 26 16121047
2021 From Bite to Byte: Dental Structures Resolved at a Single-Cell Resolution. Journal of dental research 25 33764175
2014 Frederiksenia canicola gen. nov., sp. nov. isolated from dogs and human dog-bite wounds. Antonie van Leeuwenhoek 25 24510449
2004 Immune and histopathologic examination of flea bite-induced papular urticaria. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 25 15104197
2022 CD19-targeted BiTE expression by an oncolytic vaccinia virus significantly augments therapeutic efficacy against B-cell lymphoma. Blood cancer journal 23 35228544
2013 Insect bite reactions. Indian journal of dermatology, venereology and leprology 23 23442453
2014 Biting back: BiTE antibodies as a promising therapy for acute myeloid leukemia. Expert review of hematology 22 24617311
2024 Tick bite-induced alpha-gal syndrome and immunologic responses in an alpha-gal deficient murine model. Frontiers in immunology 21 38390396
2018 A bite so sweet: the glycobiology interface of tick-host-pathogen interactions. Parasites & vectors 21 30428923
2015 Cep70 regulates microtubule stability by interacting with HDAC6. FEBS letters 21 26112604
2014 Characterization of bispecific T-cell Engager (BiTE) antibodies with a high-capacity T-cell dependent cellular cytotoxicity (TDCC) assay. Journal of biomolecular screening 21 25477202
2008 Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever. The Journal of infection 21 19091423
2013 Tumor and T cell engagement by BiTE. Discovery medicine 20 24099669
2021 Loss of CEP70 function affects acrosome biogenesis and flagella formation during spermiogenesis. Cell death & disease 19 33980814
2019 Expression of Ihh signaling pathway in condylar cartilage after bite-raising in adult rats. Journal of molecular histology 19 31302828
2014 Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo. Cancer 19 25251053
2011 Differential aging of bite and jump performance in virgin and mated Teleogryllus commodus crickets. Evolution; international journal of organic evolution 18 22023581
2018 Rat-Bite Fever in Human with Streptobacillus notomytis Infection, Japan. Emerging infectious diseases 17 29912693
2023 Comprehensive Deciphering the Complexity of the Deep Bite: Insight from Animal Model to Human Subjects. Journal of personalized medicine 16 37888083
2021 Novel immune engagers and cellular therapies for metastatic castration-resistant prostate cancer: do we take a BiTe or ride BiKEs, TriKEs, and CARs? Prostate cancer and prostatic diseases 16 34035459
2013 Immunogenomic analysis of insect bite hypersensitivity in a model horse population. Veterinary immunology and immunopathology 16 23351640
2020 Dog-bite-related attacks: A new forensic approach. Forensic science international 15 32200306
1992 Drug-associated "bite cell" hemolytic anemia. The American journal of medicine 15 1546722
2018 Lutzomyia longipalpis Saliva Induces Heme Oxygenase-1 Expression at Bite Sites. Frontiers in immunology 14 30546363
2016 Cep70 overexpression stimulates pancreatic cancer by inducing centrosome abnormality and microtubule disorganization. Scientific reports 14 26893288
2021 BiTE secretion from in situ-programmed myeloid cells results in tumor-retained pharmacology. Journal of controlled release : official journal of the Controlled Release Society 13 34953983
2018 A gB/CD3 bispecific BiTE antibody construct for targeting Human Cytomegalovirus-infected cells. Scientific reports 13 30487534
2017 Treatment of the first bite syndrome. Acta otorrinolaringologica espanola 13 28118925
2013 Analysis and identification of bite marks in forensic casework. Oral health and dental management 13 24352302
2012 Cep70 promotes microtubule assembly in vitro by increasing microtubule elongation. Acta biochimica et biophysica Sinica 13 22427462
2012 Microbial analysis of bite marks by sequence comparison of streptococcal DNA. PloS one 13 23284761
2011 Scaffolding function of the Chlamydomonas procentriole protein CRC70, a member of the conserved Cep70 family. Journal of cell science 13 21878503
2008 Forensic dentistry: 2. Bitemarks and bite injuries. Dental update 13 18277695
1998 Mosquito bite hypersensitivity. Allergologia et immunopathologia 13 9885733
2021 BiTE-ing into Prostate Cancer with Bispecific T-cell Engagers. Clinical cancer research : an official journal of the American Association for Cancer Research 12 33707179
2014 Immune responses to ectoparasites of horses, with a focus on insect bite hypersensitivity. Parasite immunology 12 25180696
2022 Bite-size introduction to canine hematologic malignancies. Blood advances 11 35316831

Missed literature

Know a paper Affinage missed for CEP70? Flag it for the maintainers and the community.

No submissions yet.